TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2664631

Group type: EXPERIMENTAL
Intervention: Combination of 12 interrupted 10‐0 sutures with a single running 11‐0 suture (IR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Double running 10‐0 and 11‐0 sutures (DR)
Number of subjects: 120
Study: 765528

Group type: EXPERIMENTAL
Intervention: Metaproterenol syrup
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo syrup
Number of subjects: 50
Study: 30421863

Group type: EXPERIMENTAL
Intervention: OPTIFAST program (OP)
Number of subjects: 273

Group type: COMPARATOR
Intervention: Food-based dietary plan (FB)
Number of subjects: 273
Study: 27918661

Group type: EXPERIMENTAL
Intervention: Power nap
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Systematic breathing
Number of subjects: 34

Group type: COMPARATOR
Intervention: Disturbed conditions
Number of subjects: 34

Group type: COMPARATOR
Intervention: Nondisturbed conditions
Number of subjects: 34
Study: 25452437

Group type: EXPERIMENTAL
Intervention: Exercise (150 minutes per week of aerobic exercise and supervised strength training twice per week)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 121
Study: 22795715

Group type: EXPERIMENTAL
Intervention: Microplegia (Mic)
Number of subjects: 80
Study: 21585704

Group type: EXPERIMENTAL
Intervention: BevCG (bevacizumab plus cisplatin-gemcitabine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CP (cisplatin plus pemetrexed)
Number of subjects: 0
Study: 19854376

Group type: EXPERIMENTAL
Intervention: Soymilk (3 servings of vanilla soy per day for 4 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Reduced fat dairy (3 servings per day for 4 weeks)
Number of subjects: 31
Study: 16711170

Group type: EXPERIMENTAL
Intervention: Hydrocolloid-based adhesive dressings
Number of subjects: 45

Group type: COMPARATOR
Intervention: Polyurethane adhesive dressing
Number of subjects: 45

Group type: COMPARATOR
Intervention: Soft silicone adhesive dressing
Number of subjects: 45
Study: 14764775

Group type: COMPARATOR
Intervention: 100 microg octreotide
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 microg SOM230
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 250 microg SOM230
Number of subjects: 12

Group type: COMPARATOR
Intervention: octreotide
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SOM230
Number of subjects: 12
Study: 11848115

Group type: EXPERIMENTAL
Intervention: Auditory, tactile, visual, and vestibular intervention (ATVV) administered for 15 minutes, twice daily, 5 days per week, from 33 weeks of age until discharge.
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Auditory, tactile, visual, and vestibular intervention (ATVV)
Number of subjects: 37
Study: 9666367

Group type: EXPERIMENTAL
Intervention: Educational interventions (classroom only, parent-child)
Number of subjects: 407

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 407
Study: 8597883

Group type: EXPERIMENTAL
Intervention: Indomethacin, diclofenac, and naproxen (nonsteroidal anti-inflammatory drugs)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2693074

Group type: EXPERIMENTAL
Intervention: maprotiline 75 mg
Number of subjects: 1141

Group type: EXPERIMENTAL
Intervention: maprotiline 37.5 mg (1/2 tablet)
Number of subjects: 1141

Group type: COMPARATOR
Intervention: placebo 1 tablet
Number of subjects: 1141

Group type: COMPARATOR
Intervention: placebo 37.5 mg (1/2 tablet)
Number of subjects: 1141
Study: 352195

Group type: EXPERIMENTAL
Intervention: RO 21‐3981 0.15 mg/kg
Number of subjects: 75

Group type: COMPARATOR
Intervention: diazepam
Number of subjects: 75

Group type: COMPARATOR
Intervention: thiopental
Number of subjects: 75
Study: 30885233

Group type: EXPERIMENTAL
Intervention: Depressed patients (defined as ≥8 points on the Hospital Anxiety and Depression Scale)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Non-depressed patients
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Use of antidepressants
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: HDL-cholesterol levels (per mmol/l)
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Abdominal obesity in women
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: HDL-cholesterol levels
Number of subjects: 292
Study: 27768515

Group type: EXPERIMENTAL
Intervention: DTPa-IPV/Hib (3 doses at 2-3-4 months)
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: DTPa-IPV/Hib (3 doses at 3-4-5 months)
Number of subjects: 984

Group type: COMPARATOR
Intervention: Control group (DTPa/Hib and IPV vaccination at 2-3-4 months)
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: DTPa-IPV/Hib (3 doses)
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: DTPa-IPV/Hib (Group A)
Number of subjects: 984
Study: 26747218

Group type: EXPERIMENTAL
Intervention: Bag-valve-mask + nasal cannula at 10 L/min
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nonrebreather face mask + nasal cannula at 10 L/min
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bag-valve-mask alone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonrebreather face mask alone
Number of subjects: 60
Study: 24934646

Group type: EXPERIMENTAL
Intervention: Lifestyle Change plus Dental Care (LCDC) program
Number of subjects: 132

Group type: COMPARATOR
Intervention: Routine program (Control)
Number of subjects: 132
Study: 23156974

Group type: EXPERIMENTAL
Intervention: Midazolam (2 mg/kg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Flumazenil (0.05 mg/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline solution (control)
Number of subjects: 9
Study: 19528136

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 8028

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 8028

Group type: EXPERIMENTAL
Intervention: Sequential therapy (2 years of one agent followed by 3 years of the other)
Number of subjects: 8028
Study: 17340069

Group type: EXPERIMENTAL
Intervention: Wobe-Mugos E (proteolytic enzymes) comprising papain 100 mg, trypsin 40 mg, and chymotrypsin 40 mg
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 15206666

Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) low-dose isradipine (15 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) high-dose isradipine (30 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Low-dose cocaine HCl (0.325 mg/kg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-dose cocaine HCl (0.650 mg/kg)
Number of subjects: 18
Study: 11409597

Group type: EXPERIMENTAL
Intervention: Antistatic measures to reduce static electric fields in visual display units
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group working with visual display units without antistatic measures
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intervention group with office dust concentration >58 microg/m3
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group with office dust concentration >58 microg/m3
Number of subjects: 120
Study: 9207592

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (normal ovarian cycles)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: POF without HRT
Number of subjects: 24
Study: 7963223

Group type: EXPERIMENTAL
Intervention: Polarized‐free tests (Titmus, Reindeer, Butterfly, Figures)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Polarized tests (Titmus, Reindeer, Butterfly, Figures)
Number of subjects: 34
Study: 3117399

Group type: EXPERIMENTAL
Intervention: Sequential instillation of mitomycin C (MMC) and adriamycin (ADM); 20 mg MMC on day 1 and 40 mg ADM on day 2, repeated weekly for 5 weeks.
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Intermittent instillation of MMC
Number of subjects: 84

Group type: COMPARATOR
Intervention: 5‐fluorouracil (5‐FU) medication
Number of subjects: 84
Study: 28739443

Group type: EXPERIMENTAL
Intervention: HAsauna (sauna exposure at 50°C, 30% RH)
Number of subjects: 9

Group type: COMPARATOR
Intervention: HAtemp (temperate environment at 20°C, 40% RH)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: HAsauna
Number of subjects: 9

Group type: COMPARATOR
Intervention: HAtemp
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: HAsauna and HAtemp
Number of subjects: 9
Study: 26347218

Group type: EXPERIMENTAL
Intervention: α-lipoic acid (ALA) treatment (600mg once daily)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 24978844

Group type: EXPERIMENTAL
Intervention: Seeking Safety (SS)
Number of subjects: 353

Group type: COMPARATOR
Intervention: Women's Health Education (WHE)
Number of subjects: 353
Study: 22822623

Group type: EXPERIMENTAL
Intervention: N. sativa capsules (500 +/- 10 mg per capsule, 2 g per day for 4 weeks)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo (matching placebo)
Number of subjects: 88
Study: 20727129

Group type: EXPERIMENTAL
Intervention: Melaleuca oil and lavender oil (TTO/LO)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Head lice 'suffocation' product
Number of subjects: 123

Group type: COMPARATOR
Intervention: Pyrethrins and piperonyl butoxide (P/PB)
Number of subjects: 123
Study: 18441041

Group type: EXPERIMENTAL
Intervention: Sensorimotor training programme using a sling suspension system
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine physical therapy (Control)
Number of subjects: 60
Study: 16401986

Group type: EXPERIMENTAL
Intervention: Cold crystalloid cardioplegia by antegrade route (Group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Warm blood cardioplegia by antegrade route (Group 2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Antegrade/retrograde warm blood cardioplegia (Group 3)
Number of subjects: 30
Study: 12556017

Group type: EXPERIMENTAL
Intervention: 150 ml paper disposable cup
Number of subjects: 50

Group type: COMPARATOR
Intervention: commercially produced spacer
Number of subjects: 50
Study: 11022875

Group type: EXPERIMENTAL
Intervention: Multivitamin/mineral supplement
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 8892717

Group type: EXPERIMENTAL
Intervention: Tunneled catheters
Number of subjects: 231

Group type: COMPARATOR
Intervention: Nontunneled catheters (Control)
Number of subjects: 231
Study: 1524967

Group type: EXPERIMENTAL
Intervention: Hirudin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3158187

Group type: EXPERIMENTAL
Intervention: Diltiazem, 90 mg three times a day by mouth for 3 months after PTCA
Number of subjects: 92

Group type: COMPARATOR
Intervention: Calcium antagonists discontinued immediately after PTCA (Control)
Number of subjects: 92
Study: 29996492

Group type: EXPERIMENTAL
Intervention: IF 1 (1.0 g protein/dL)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: IF 2 (1.3 g protein/dL)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: IF 3 (1.5 g protein/dL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: HM (exclusively breastfed)
Number of subjects: 30
Study: 26201313

Group type: EXPERIMENTAL
Intervention: Weekly adalimumab
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Every other week adalimumab
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 26337327

Group type: EXPERIMENTAL
Intervention: Clinician feedback group (received feedback weekly)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Control group (did not receive feedback)
Number of subjects: 299
Study: 23099730

Group type: COMPARATOR
Intervention: 30% FiO2
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: 80% FiO2
Number of subjects: 171
Study: 20642454

Group type: EXPERIMENTAL
Intervention: Brisk walking (6 days/week for approx. 50 min/day for 8 weeks)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Endurance exercise training
Number of subjects: 26

Group type: COMPARATOR
Intervention: Non-exercising controls
Number of subjects: 26
Study: 18215618

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment (substrates of ABCB1)
Number of subjects: 0
Study: 16377916

Group type: EXPERIMENTAL
Intervention: Nasal nocturnal oxygen therapy (HOT group, n=25)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual breathing (control group, n=31)
Number of subjects: 56
Study: 14651540

Group type: EXPERIMENTAL
Intervention: Tolmetin (25 mg/kg per day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Aspirin (75-100 mg/kg per day)
Number of subjects: 72
Study: 10985712

Group type: EXPERIMENTAL
Intervention: Mitral valve surgery (n = 43)
Number of subjects: 98

Group type: COMPARATOR
Intervention: No mitral valve surgery (n = 51)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Cohort with severe mitral regurgitation (MR, n = 98)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Cohort with predominant left ventricular failure (LVF, n = 879)
Number of subjects: 98
Study: 8972376

Group type: EXPERIMENTAL
Intervention: Oxygen inhalation during surgery
Number of subjects: 31

Group type: COMPARATOR
Intervention: Air inhalation during surgery
Number of subjects: 31
Study: 1592575

Group type: EXPERIMENTAL
Intervention: Selegiline (a selective MAO-B inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6375274

Group type: EXPERIMENTAL
Intervention: Morphine 10 mg/ml
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Nicomorphine 10 mg/ml
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Pethidine 75 mg/ml
Number of subjects: 275
Study: 30664050

Group type: EXPERIMENTAL
Intervention: Active transcranial direct current stimulation with methadone maintenance treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation with methadone maintenance treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Only methadone maintenance treatment
Number of subjects: 60
Study: 29565950

Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency (PRF) on the ilioinguinal nerve and genital branch of the genitofemoral nerve
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 70
Study: 27380105

Group type: COMPARATOR
Intervention: Interscalene block (ISB)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Suprascapular and axillary nerve block (SSAX)
Number of subjects: 60
Study: 23012688

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 4408

Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 4408
Study: 22340283

Group type: EXPERIMENTAL
Intervention: AZD9773 (50 or 250 units/kg single doses; multiple doses of 250 units/kg loading and 50 units/kg maintenance, 500 units/kg loading and 100 units/kg maintenance, or 750 units/kg loading and 250 units/kg maintenance)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 19877169

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RSG), 8 mg/day for 2 years
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (PLB) followed by Rosiglitazone (RSG)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RSG) for 2 additional years after initial treatment
Number of subjects: 44
Study: 17510102

Group type: EXPERIMENTAL
Intervention: Screening for problematic alcohol consumption using the Alcohol Use Disorders Identification Test
Number of subjects: 3003

Group type: EXPERIMENTAL
Intervention: Referral behaviour of physicians
Number of subjects: 3003
Study: 15984513

Group type: EXPERIMENTAL
Intervention: Platinum-based chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Uracil-tegafur
Number of subjects: 0
Study: 12105140

Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg/d)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 10420109

Group type: EXPERIMENTAL
Intervention: Lomefloxacin 0.3% eye drops twice daily
Number of subjects: 99

Group type: COMPARATOR
Intervention: Tobramycin 0.3% eye drops 4 times daily
Number of subjects: 99
Study: 7498114

Group type: EXPERIMENTAL
Intervention: Participants who rated negative affect situations as most difficult
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Participants who generated coping responses to more situations
Number of subjects: 93
Study: 1341875

Group type: EXPERIMENTAL
Intervention: Captopril associated with conventional treatment (digitalis and diuretic)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Captopril associated with digitalis or diuretic
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional treatment (digitalis and diuretic)
Number of subjects: 20
Study: 6659641

Group type: EXPERIMENTAL
Intervention: Penbutolol (negative inotropic agent)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: AR‐L 115 BS (positive inotropic drug)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Penbutolol during atrial pacing
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control values under physiological conditions
Number of subjects: 23
Study: 30924348

Group type: EXPERIMENTAL
Intervention: Application of previously published criteria for GPA diagnosis
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Application of antineutrophil cytoplasm autoantibody testing and the European Medicines Agency algorithm
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Generalized disease
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Interobserver correlation among pathologists
Number of subjects: 132
Study: 29378016

Group type: COMPARATOR
Intervention: Pregabalin (150 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: ASP9226 (30 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: ASP9226 (50 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 24
Study: 27225949

Group type: EXPERIMENTAL
Intervention: Late follicular phase (day 14)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Indomethacin (COX inhibition)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Early follicular phase (day 3)
Number of subjects: 11
Study: 24520664

Group type: EXPERIMENTAL
Intervention: L-carnitine + tadalafil
Number of subjects: 110

Group type: COMPARATOR
Intervention: Testosterone undecanoate + tadalafil
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Safety of medication
Number of subjects: 110
Study: 22847195

Group type: EXPERIMENTAL
Intervention: Vitamins (1000 mg of vitamin C, 800 IU of vitamin E, and 300 mg of Coenzyme Q‐10) for 14 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High fat (HF) meal
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low fat (LF) meal
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 20
Study: 20014878

Group type: EXPERIMENTAL
Intervention: Erlotinib 150 mg/day
Number of subjects: 0
Study: 17589629

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with epinephrine
Number of subjects: 62

Group type: COMPARATOR
Intervention: 2% lidocaine without epinephrine
Number of subjects: 62
Study: 15805347

Group type: EXPERIMENTAL
Intervention: Combined dietary-behavioral-physical activity intervention
Number of subjects: 46
Study: 12151908

Group type: EXPERIMENTAL
Intervention: Donepezil (DPZ) 10 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vitamin E 2000 IU/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison of Donepezil vs Vitamin E
Number of subjects: 60
Study: 10539746

Group type: EXPERIMENTAL
Intervention: 1-MJ snack consumed 5 min before individual peak of hyperglycemia
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 1-MJ snack consumed 40 min after individual peak of hyperglycemia
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 1-MJ snack consumed 120 min before the time of dinner request
Number of subjects: 11
Study: 8665881

Group type: EXPERIMENTAL
Intervention: Neostigmine (0.036 mg kg‐1)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Spontaneous recovery
Number of subjects: 46
Study: 1669490

Group type: EXPERIMENTAL
Intervention: VitaStat
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Dinamap
Number of subjects: 159

Group type: COMPARATOR
Intervention: Manual measurement
Number of subjects: 159
Study: 7193006

Group type: EXPERIMENTAL
Intervention: Fluorimetric method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HPLC methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microbiological methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall comparison of methods
Number of subjects: 0
Study: 30586695

Group type: EXPERIMENTAL
Intervention: Patisiran (0.3 mg/kg via intravenous infusion once every 3 weeks for 18 months)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Patisiran
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 28372660

Group type: EXPERIMENTAL
Intervention: Unidirectional turbulent free laminar airflow system
Number of subjects: 80

Group type: COMPARATOR
Intervention: Absence of unidirectional turbulent free laminar airflow system
Number of subjects: 80

Group type: COMPARATOR
Intervention: Longer duration of surgery
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Forced air warming system
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Electric warming system
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Number of health professionals in the OR
Number of subjects: 80
Study: 26825829

Group type: EXPERIMENTAL
Intervention: Paclitaxel (PTX, 175 mg/m²) plus Carboplatin (CBDCA) (TC chemotherapy)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Docetaxel (DTX, 60 mg/m²) plus Carboplatin (CBDCA) (DC chemotherapy)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Both TC and DC chemotherapy
Number of subjects: 37
Study: 25902653

Group type: EXPERIMENTAL
Intervention: Meldonium (1 g/day intravenously for 2 weeks then orally until 1.5 months)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Meldonium
Number of subjects: 140
Study: 22087585

Group type: EXPERIMENTAL
Intervention: 1.8 g/day free plant sterols and stanols
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 18713481

Group type: EXPERIMENTAL
Intervention: Nutritional intervention
Number of subjects: 20